-
公开(公告)号:US20220241484A1
公开(公告)日:2022-08-04
申请号:US17433761
申请日:2020-03-06
申请人: GAMBRO LUNDIA AB
发明人: Jan SWARTJES , Markus STORR , Martin REMPFER , Isabelle LITZINGER , Stefanie VOTTELER , Philipp KUHN
摘要: The invention relates to a blood treatment device configured to dephosphorylate extracellular adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP) and/or lipopolysaccharide (LPS) in the blood of a patient in need thereof in an extracorporeal blood circuit, wherein the device comprises a matrix having alkaline phosphatase (AP) immobilized thereon. The invention further relates to an extracorporeal blood circuit comprising a blood treatment device of the invention and to the blood treatment device for use as a medicament or to methods of treating an infection, preferably a blood or systemic infection, such as sepsis, and/or for the treatment of sepsis-associated acute kidney injury (AKI).
-
公开(公告)号:US20160207009A1
公开(公告)日:2016-07-21
申请号:US14915520
申请日:2014-09-03
申请人: GAMBRO LUNDIA AB
发明人: Ralf MENDA , Martin REMPFER , Joachim LOERCHER
CPC分类号: B01D71/28 , B01D63/023 , B01D67/0011 , B01D69/06 , B01D69/08 , B01D71/68 , B01D2325/34
摘要: The present invention relates to membranes being suitable e.g. for hemodialysis, hemodiafiltration, or hemofiltration of blood. The invention also relates to a process for the production of the membranes; and to devices comprising the membranes.
摘要翻译: 本发明涉及例如适合的膜。 用于血液透析,血液透析滤过或血液滤过。 本发明还涉及一种生产膜的方法; 以及包括膜的装置。
-